未登录

P

Pei-Hsing Chen

national taiwan university hospital

H指数:6

被引数:150

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Association Between Unenhanced CT Features and Perioperative Outcomes in Bronchogenic Cyst Resection

支气管囊肿切除术中未增强CT特征与围手术期结局的关系

IF3.3

2026-09-170

OA

PP01.73: Pre-Operative Nucleosome Liquid Biopsy for Risk Stratification of Lung Cancer

PP01.73: 术前核小体液体活检用于肺癌的风险分层

Journal of Thoracic Oncology

IF20.8

2026-05-070

PRE

Coccidioidomycosis: an emerging disease in Taiwan

球孢子菌病: 台湾的一种新兴疾病

Journal of the Formosan Medical Association

IF2.5

2026-01-080

OAAI

Accurate Diagnosis of High-Risk Pulmonary Nodules Using a Non-Invasive Epigenetic Biomarker Test

使用非侵入性表观遗传生物标志物检测对高风险肺结节进行准确诊断

IF4.4

2025-03-071

OA

ASO Visual Abstract: Tumor Spread Through Air Spaces Predicts Survival in Resected Pulmonary Lymphoepithelial Carcinoma

ANNALS OF SURGICAL ONCOLOGY

IF3.5

2024-12-030

PRE

ASO Author Reflections: Tumor Spread Through Air Spaces Predicts Survival in Resected Pulmonary Lymphoepithelial Carcinoma

ANNALS OF SURGICAL ONCOLOGY

IF3.5

2024-11-300

PRE

Tumor Spread Through Air Spaces Predicts Survival in Resected Pulmonary Lymphoepithelial Carcinoma (Nov, 10.1245/S10434-024-16401-7, 2024)

ANNALS OF SURGICAL ONCOLOGY

IF3.5

2024-11-150

OA

Tumor Spread Through Air Spaces Predicts Survival in Resected Pulmonary Lymphoepithelial Carcinoma

肿瘤通过空气空间扩散可预测切除的肺淋巴上皮癌的生存率

ANNALS OF SURGICAL ONCOLOGY

IF3.5

2024-11-043

PRE

An interaction between PM10 and periodontitis may contribute to chronic obstructive pulmonary disease among non-smoking Taiwanese populations

ATMOSPHERIC POLLUTION RESEARCH

IF3.5

2023-12-010

PRE

Differentiation of malignant and benign lung nodules using epigenetically modified nucleosomes in plasma

ANNALS OF ONCOLOGY

IF65.4

2023-10-010

PRE

Computed Tomography-Guided Localization and Extended Segmentectomy for Non-Small Cell Lung Cancer

IF3.3

2022-08-243

OAAI

ASO Visual Abstract: Primary Tumor Resection for Stage IV Non-Small-Cell Lung Cancer Without Progression After First-Line Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Treatment: A Retrospective Case-Control Study

ANNALS OF SURGICAL ONCOLOGY

IF3.5

2022-05-150

PRE

Primary Tumor Resection for Stage IV Non-small-cell Lung Cancer Without Progression After First-Line Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Treatment: A Retrospective Case-Control Study (Mar, 10.1245/S10434-022-11483-7, 2022)

ANNALS OF SURGICAL ONCOLOGY

IF3.5

2022-04-090

OA

ASO Author Reflection: Primary Tumor Resection for Stage IV Lung Cancer after Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor

ANNALS OF SURGICAL ONCOLOGY

IF3.5

2022-03-210

PRE

Primary Tumor Resection for Stage IV Non-small-cell Lung Cancer Without Progression After First-Line Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Treatment: A Retrospective Case-Control Study

ANNALS OF SURGICAL ONCOLOGY

IF3.5

2022-03-0712

PRE

Vicryl Mesh Coverage Reduced Recurrence After Bullectomy for Primary Spontaneous Pneumothorax

ANNALS OF THORACIC SURGERY

IF3.9

2021-11-0110

PREAI

Nonintubated Versus Intubated Uniportal Thoracoscopic Segmentectomy for Lung Tumors

ANNALS OF THORACIC SURGERY

IF3.9

2021-04-0116

OAAI

Management of Patients With Circumferential Intramural Esophageal Dissection

ANNALS OF THORACIC SURGERY

IF3.9

2019-07-010

OAAI

Preoperative Dye Localization for Thoracoscopic Lung Surgery: Hybrid Versus Computed Tomography Room

ANNALS OF THORACIC SURGERY

IF3.9

2018-12-0136

OAAI